18F-FDG PET/CT and MRI in the follow-up of head and neck squamous cell carcinoma

Contrast Media and Molecular Imaging

Volumn 6, Issue 4, 2011, Pages 260-266

  Ghanooni, Rose ^a   Delpierre, Isabelle ^a   Magremanne, Michèle ^a   Vervaet, Catherine ^a   Dumarey, Nicolas ^a   Remmelink, Myriam ^a   Lacroix, Simon ^a   Trotta, Nicola ^a   Hassid, Sergio ^a   Goldman, Serge ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

18F FDG PET; Fluorodeoxyglucose; Head and neck cancer; MRI; Squamous cell carcinoma

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER SURGERY; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; EARLY DIAGNOSIS; FEMALE; FOLLOW UP; HEAD AND NECK CARCINOMA; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTIVE VALUE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SQUAMOUS CELL CARCINOMA; HEAD AND NECK TUMOR; METHODOLOGY; MIDDLE AGED; POSITRON EMISSION TOMOGRAPHY; PROSPECTIVE STUDY; RADIOGRAPHY;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; FEMALE; FLUORODEOXYGLUCOSE F18; HEAD AND NECK NEOPLASMS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES;

EID: 80051935075     PISSN: 15554309     EISSN: 15554317     Source Type: Journal    
DOI: 10.1002/cmmi.425     Document Type: Article

References (34)

1. Yom SS, Machtay M, Biel MA, Sinard RJ, El-Naggar AK, Weber RS, Rosenthal DI. Survival impact of planned restaging and early surgical salvage following definitive chemoradiation for locally advanced squamous cell carcinomas of the oropharynx and hypopharynx. Am J Clin Oncol 2005; 28: 385-392.
2. Gordin A, Golz A, Keidar Z, Daitzchman M, Bar-Shalom R, Israel O. The role of FDG-PET/CT imaging in head and neck malignant conditions: impact on diagnostic accuracy and patient care. Otolaryngol Head Neck Surg 2007; 137: 130-137.
3. Jeong HS, Baek CH, Son YI, Ki Chung M, Kyung Lee D, Young Choi J, Kim BT, Kim HJ. Use of integrated 18F-FDG PET/CT to improve the accuracy of initial cervical nodal evaluation in patients with head and neck squamous cell carcinoma. Head Neck 2007; 29: 203-210.
4. Wong RJ. Current status of FDG-PET for head and neck cancer. J Surg Oncol 2008; 97: 649-652.
5. Abgral R, Querellou S, Potard G, Le Roux PY, Le Duc-Pennec A, Marianovski R, Pradier O, Bizais Y, Kraeber-Bodéré F, Salaun PY. Does 18F-FDG PET/CT improve the detection of posttreatment recurrence of head and neck squamous cell carcinoma in patients negative for disease on clinical follow-up? J Nucl Med 2009; 50: 24-29.
6. Kao J, Vu HL, Genden EM, Mocherla B, Park EE, Packer S, Som PM, Kostakoglu L. The diagnostic and prognostic utility of positron emission tomography/computed tomography-based follow-up after radiotherapy for head and neck cancer. Cancer 2009; 115: 4586-4594.
7. Goerres GW, Schmid DT, Bandhauer F, Huguenin PU, von Schulthess GK, Schmid S, Stoeckli SJ. Positron emission tomography in the early follow-up of advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 2004; 130: 105-109; discussion 120-101.
8. Kim SY, Lee SW, Nam SY, Im KC, Kim JS, Oh SJ, Ahn SD, Shin SS, Choi EK, Kim JH. The Feasibility of 18F-FDG PET scans 1 month after completing radiotherapy of squamous cell carcinoma of the head and neck. J Nucl Med 2007; 48: 373-378.
9. Nam SY, Lee SW, Im KC, Kim JS, Kim SY, Choi SH, Ryu JS, Moon DH, Oh SJ, Yi BY, Kim JH, Ahn SD, SHin SS, Kim SB, Choi EK, Lee BJ. Early evaluation of the response to radiotherapy of patients with squamous cell carcinoma of the head and neck using 18FDG-PET. Oral Oncol 2005; 41: 390-395.
10. Liu T, Xu W, Yan WL, Ye M, Bai YR, Huang G. FDG-PET, CT, MRI for diagnosis of local residual or recurrent nasopharyngeal carcinoma, which one is the best? A systematic review. Radiother Oncol 2007; 85: 327-335.
11. Shah JP, Strong E, Spiro RH, Vikram B. Surgical grand rounds. Neck dissection: current status and future possibilities. Clin Bull 1981; 11: 25-33.
12. Leung TW, Tung SY, Sze WK, Wong FC, Yuen KK, Lui CM, Lo SH, Ng TY, O SK. Treatment results of 1070 patients with nasopharyngeal carcinoma: an analysis of survival and failure patterns. Head Neck 2005; 27: 555-565.
13. Agra IM, Carvalho AL, Ulbrich FS, de Campos OD, Martins EP, Magrin J, Kowalski LP. Prognostic factors in salvage surgery for recurrent oral and oropharyngeal cancer. Head Neck 2006; 28: 107-113.
14. Chopra S, Gupta T, Agarwal JP, Budrukkar A, Ghosh-Laskar S, Dinshaw K. Re-irradiation in the management of isolated neck recurrences: current status and recommendations. Radiother Oncol 2006; 81: 1-8.
15. Ganly I, Patel SG, Matsuo J, Singh B, Kraus DH, Boyle JO, Wong RJ, Shaha AR, Lee N, Shah JP. Results of surgical salvage after failure of definitive radiation therapy for early-stage squamous cell carcinoma of the glottic larynx. Arch Otolaryngol Head Neck Surg 2006; 132: 59-66.
16. Jeong WJ, Jung YH, Kwon SK, Hah JH, Kwon TK, Sung MW, Kim KH. Role of surgical salvage for regional recurrence in laryngeal cancer. Laryngoscope 2007; 117: 74-77.
17. Koo BS, Lim YC, Lee JS, Choi EC. Recurrence and salvage treatment of squamous cell carcinoma of the oral cavity. Oral Oncol 2006; 42: 789-794.
18. Kupferman ME, Morrison WH, Santillan AA, Roberts D, Diaz EM Jr, Garden AS, Weber R. The role of interstitial brachytherapy with salvage surgery for the management of recurrent head and neck cancers. Cancer 2007; 109: 2052-2057.
19. Langendijk JA, Bourhis J. Reirradiation in squamous cell head and neck cancer: recent developments and future directions. Curr Opin Oncol 2007; 19: 202-209.
20. Li P, Zhuang H, Mozley PD, Denittis A, Yeh D, Machtay M, Smith R, Alavi A. Evaluation of recurrent squamous cell carcinoma of the head and neck with FDG positron emission tomography. Clin Nucl Med 2001; 26: 131-135.
21. Liao CT, Chang JT, Wang HM, Ng SH, Hsueh C, Lee LY, Lin CH, Chen IH, Huang SF, Cheng AJ, Yen TC. Salvage therapy in relapsed squamous cell carcinoma of the oral cavity: how and when? Cancer 2008; 112: 94-103.
22. Ord RA, Kolokythas A, Reynolds MA. Surgical salvage for local and regional recurrence in oral cancer. J Oral Maxillofac Surg 2006; 64: 1409-1414.
23. Schwartz GJ, Mehta RH, Wenig BL, Shaligram C, Portugal LG. Salvage treatment for recurrent squamous cell carcinoma of the oral cavity. Head Neck 2000; 22: 34-41.
24. Studer G, Graetz KW, Glanzmann C. Outcome in recurrent head neck cancer treated with salvage-IMRT. Radiat Oncol 2008; 3: 43.
25. Brouwer J, Hooft L, Hoekstra OS, Riphagen II, Castelijns JA, de Bree R, Leemans CR. Systematic review: accuracy of imaging tests in the diagnosis of recurrent laryngeal carcinoma after radiotherapy. Head Neck 2008; 30: 889-897.
26. Haberkorn U, Strauss LG, Reisser C, Haag D, Dimitrakopoulou A, Ziegler S, Reisser C, Doll J, Helus F, van Kaick G. Glucose uptake, perfusion, and cell proliferation in head and neck tumors: relation of positron emission tomography to flow cytometry. J Nucl Med 1991; 32: 1548-1555.
27. Jacob R, Welkoborsky HJ, Mann WJ, Jauch M, Amedee R. [Fluorine-18]fluorodeoxyglucose positron emission tomography, DNA ploidy and growth fraction in squamous-cell carcinomas of the head and neck. J Otorhinolaryngol Relat Spec 2001; 63: 307-313.
28. Daisne JF, Duprez T, Weynand B, Lonneux M, Hamoir M, Reychler H, Grégoire V. Tumor volume in pharyngolaryngeal squamous cell carcinoma: comparison at CT, MR imaging, and FDG PET and validation with surgical specimen. Radiology 2004; 233: 93-100.
29. Yoshida K, Suzuki A, Nagashima T, Lee J, Horiuchi C, Tsukuda M, Inoue T. Staging primary head and neck cancers with 18F-FDG PET/CT: is intravenous contrast administration really necessary ? Eur J Nucl Med Mol Imag 2009; 36: 1417-1424.
30. Rodrigues RS, Bozza FA, Christian PE, Hoffman JM, Butterfield RI, Christensen CR, Heilbrun M, Wiggins RH 3rd, Hunt JP, Bentz BG, Hitchcock YJ, Morton KA. Comparison of whole-body PET/CT dedicated high-resolution head and neck PET/CT, and contrast-enhanced CT in preoperative staging of clinically M0 squamous cell carcinoma of the head and neck. J Nucl Med 2009; 50: 1205-1213.
31. Krabbe CA, van der Werff-Regelink G, Pruim J, van der Wal JE, and Roodenburg JL. Detection of cervical metastases with (11)C-tyrosine PET in patients with squamous carcinoma of the oral cavity or oropharynx: a comparison with (18)F-FDG PET. Head Neck 2010; 32: 368-374.
32. Sutinen E, Jyrkkio S, Alanen K, Nagren K, Minn H. Uptake of [N-methyl- 11C]alpha-methylaminoisobutyric acid in untreated head and neck cancer studied by PET. Eur J Nucl Med Mol Imag 2003; 30: 72-77.
33. Troost EG, Bussink J, Hoffmann AL, Boerman OC, Oyen WJ, Kaanders JH. 18F-FLT PET/CT for early response monitoring and dose escalation in oropharyngeal tumors. J Nucl Med 2010; 51: 866-874.
34. Troost EG, Vogel WV, Merkx MA, Slootweg PJ, Marres HA, Peeters WJ, Bussink J, van der Kogel AJ, Oyen WJ, Kaanders JH. 18F-FLT PET does not discriminate between reactive and metastatic lymph nodes in primary head and neck cancer patients. J Nucl Med 2007; 48: 726-735.